Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Bioluminescence imaging to evaluate infections and host response in vivo.

Contag PR.

Methods Mol Biol. 2008;415:101-18. doi: 10.1007/978-1-59745-570-1_6.

PMID:
18370150
2.

Expression of firefly luciferase in Candida albicans and its use in the selection of stable transformants.

Doyle TC, Nawotka KA, Purchio AF, Akin AR, Francis KP, Contag PR.

Microb Pathog. 2006 Feb;40(2):69-81. Epub 2006 Jan 20.

PMID:
16427765
3.

Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene.

Doyle TC, Nawotka KA, Kawahara CB, Francis KP, Contag PR.

Microb Pathog. 2006 Feb;40(2):82-90. Epub 2006 Jan 19.

PMID:
16426810
4.

Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response.

Kadurugamuwa JL, Modi K, Coquoz O, Rice B, Smith S, Contag PR, Purchio T.

Infect Immun. 2005 Dec;73(12):7836-43.

5.

Noninvasive monitoring of pneumococcal meningitis and evaluation of treatment efficacy in an experimental mouse model.

Kadurugamuwa JL, Modi K, Yu J, Francis KP, Orihuela C, Tuomanen E, Purchio AF, Contag PR.

Mol Imaging. 2005 Apr-Jun;4(2):137-42.

PMID:
16105511
6.

Noninvasive biophotonic imaging for monitoring of catheter-associated urinary tract infections and therapy in mice.

Kadurugamuwa JL, Modi K, Yu J, Francis KP, Purchio T, Contag PR.

Infect Immun. 2005 Jul;73(7):3878-87.

7.

In vivo bioluminescent monitoring of chemical toxicity using heme oxygenase-luciferase transgenic mice.

Malstrom SE, Jekic-McMullen D, Sambucetti L, Ang A, Reeves R, Purchio AF, Contag PR, West DB.

Toxicol Appl Pharmacol. 2004 Nov 1;200(3):219-28.

PMID:
15504458
8.

Noninvasive optical imaging method to evaluate postantibiotic effects on biofilm infection in vivo.

Kadurugamuwa JL, Sin LV, Yu J, Francis KP, Purchio TF, Contag PR.

Antimicrob Agents Chemother. 2004 Jun;48(6):2283-7.

9.

Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer.

Scatena CD, Hepner MA, Oei YA, Dusich JM, Yu SF, Purchio T, Contag PR, Jenkins DE.

Prostate. 2004 May 15;59(3):292-303.

PMID:
15042605
10.

In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer.

Jenkins DE, Yu SF, Hornig YS, Purchio T, Contag PR.

Clin Exp Metastasis. 2003;20(8):745-56.

PMID:
14713108
11.

Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis.

Jenkins DE, Oei Y, Hornig YS, Yu SF, Dusich J, Purchio T, Contag PR.

Clin Exp Metastasis. 2003;20(8):733-44.

PMID:
14713107
12.

Effects of metalloporphyrins on heme oxygenase-1 transcription: correlative cell culture assays guide in vivo imaging.

Hajdena-Dawson M, Zhang W, Contag PR, Wong RJ, Vreman HJ, Stevenson DK, Contag CH.

Mol Imaging. 2003 Jul;2(3):138-49.

PMID:
14649057
13.

Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse.

Zhang N, Fang Z, Contag PR, Purchio AF, West DB.

Blood. 2004 Jan 15;103(2):617-26. Epub 2003 Sep 25.

14.

Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection.

Kadurugamuwa JL, Sin LV, Yu J, Francis KP, Kimura R, Purchio T, Contag PR.

Antimicrob Agents Chemother. 2003 Oct;47(10):3130-7.

15.

A transgenic mouse model with a luciferase reporter for studying in vivo transcriptional regulation of the human CYP3A4 gene.

Zhang W, Purchio AF, Chen K, Wu J, Lu L, Coffee R, Contag PR, West DB.

Drug Metab Dispos. 2003 Aug;31(8):1054-64.

PMID:
12867495
16.

An inducible nitric oxide synthase-luciferase reporter system for in vivo testing of anti-inflammatory compounds in transgenic mice.

Zhang N, Weber A, Li B, Lyons R, Contag PR, Purchio AF, West DB.

J Immunol. 2003 Jun 15;170(12):6307-19.

17.

In vivo activation of the human CYP3A4 promoter in mouse liver and regulation by pregnane X receptors.

Zhang W, Purchio A, Chen K, Burns SM, Contag CH, Contag PR.

Biochem Pharmacol. 2003 Jun 1;65(11):1889-96.

PMID:
12781341
18.

Direct continuous method for monitoring biofilm infection in a mouse model.

Kadurugamuwa JL, Sin L, Albert E, Yu J, Francis K, DeBoer M, Rubin M, Bellinger-Kawahara C, Parr TR Jr, Contag PR.

Infect Immun. 2003 Feb;71(2):882-90.

19.

Selection of potential therapeutics based on in vivo spatiotemporal transcription patterns of heme oxygenase-1.

Zhang W, Contag PR, Hardy J, Zhao H, Vreman HJ, Hajdena-Dawson M, Wong RJ, Stevenson DK, Contag CH.

J Mol Med (Berl). 2002 Oct;80(10):655-64. Epub 2002 Sep 19.

PMID:
12395150
20.

Whole-animal cellular and molecular imaging to accelerate drug development.

Contag PR.

Drug Discov Today. 2002 May 15;7(10):555-62. Review.

PMID:
12047855
21.

Revealing the spatiotemporal patterns of bacterial infectious diseases using bioluminescent pathogens and whole body imaging.

Burns SM, Joh D, Francis KP, Shortliffe LD, Gruber CA, Contag PR, Contag CH.

Contrib Microbiol. 2001;9:71-88. Review. No abstract available.

PMID:
11764723
22.

Rapid in vivo functional analysis of transgenes in mice using whole body imaging of luciferase expression.

Zhang W, Feng JQ, Harris SE, Contag PR, Stevenson DK, Contag CH.

Transgenic Res. 2001 Oct;10(5):423-34.

PMID:
11708652
23.

Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon.

Francis KP, Yu J, Bellinger-Kawahara C, Joh D, Hawkinson MJ, Xiao G, Purchio TF, Caparon MG, Lipsitch M, Contag PR.

Infect Immun. 2001 May;69(5):3350-8.

24.

Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection.

Rocchetta HL, Boylan CJ, Foley JW, Iversen PW, LeTourneau DL, McMillian CL, Contag PR, Jenkins DE, Parr TR Jr.

Antimicrob Agents Chemother. 2001 Jan;45(1):129-37.

25.

Use of reporter genes for optical measurements of neoplastic disease in vivo.

Contag CH, Jenkins D, Contag PR, Negrin RS.

Neoplasia. 2000 Jan-Apr;2(1-2):41-52. Review.

26.

Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct.

Francis KP, Joh D, Bellinger-Kawahara C, Hawkinson MJ, Purchio TF, Contag PR.

Infect Immun. 2000 Jun;68(6):3594-600.

27.

Bioluminescence for biological sensing in living mammals.

Zhang W, Contag PR, Madan A, Stevenson DK, Contag CH.

Adv Exp Med Biol. 1999;471:775-84. No abstract available.

PMID:
10659213
28.

Real-time monitoring of Escherichia coli O157:H7 adherence to beef carcass surface tissues with a bioluminescent reporter.

Siragusa GR, Nawotka K, Spilman SD, Contag PR, Contag CH.

Appl Environ Microbiol. 1999 Apr;65(4):1738-45.

29.

Bioluminescent indicators in living mammals.

Contag PR, Olomu IN, Stevenson DK, Contag CH.

Nat Med. 1998 Feb;4(2):245-7. No abstract available.

PMID:
9461201
30.

Visualizing gene expression in living mammals using a bioluminescent reporter.

Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P, Stevenson DK, Benaron DA.

Photochem Photobiol. 1997 Oct;66(4):523-31.

PMID:
9337626
31.

Imaging brain structure and function, infection and gene expression in the body using light.

Benaron DA, Contag PR, Contag CH.

Philos Trans R Soc Lond B Biol Sci. 1997 Jun 29;352(1354):755-61. Review.

32.

Photonic detection of bacterial pathogens in living hosts.

Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, Benaron DA.

Mol Microbiol. 1995 Nov;18(4):593-603.

PMID:
8817482
33.

Supplemental Content

Loading ...
Support Center